title: New insights into opioid regulatory pathways: influence of opioids on Wnt1 expression in zebrafish embryos.
abstract: Opioids are the most potent analgesics known today, but their prolonged administration produces severe adverse effects such as constipation, bradycardia, besides addiction, a concept not fully understood at present, which represents one of the most important challenges of modern bioscience. Wnts constitute an important family of vertebrate genes that encode secreted signaling proteins implicated in various developmental processes (patterning of the neural tube, neuronal differentiation), and are extensively conserved through evolution. In this study we have focused on Wnt1, an essential signal in axis polarity, as well as in proliferation and the development and differentiation of the CNS, roles shared by opioid receptors. Our previous studies in zebrafish show that morphine, the most potent analgesic known today, increases cell proliferation and induces neuronal protection and dopaminergic differentiation by activating the opioid receptors. The aim of the present study is to determine whether these effects are a consequence of an interaction between Wnt1 and the endogenous opioid system, which may act as a transcription regulator of Wnt1. Hence, we have exposed embryos to morphine, the endogenous delta opioid agonist Met-Enkephalin-Glu-Tyr (MEGY) (it binds with high affinity to both zebrafish delta opioid receptors, ZfDORs), and SNC80, a highly specific delta agonist, which displays low affinity towards the ZfDORs. Although at earlier stages, all opioids reduced the expression level of Wnt1, further on development, mainly during the differentiation of the CNS (24-48 h post fertilization (hpf)), morphine and MEGY increased Wnt1 expression. Our results point to the possibility that opioid signaling controls the transcription of Wnt1 and that through Wnt1, the opioid system regulates cell proliferation and neuronal differentiation. The present work opens a door to the discovery of new mechanisms that regulate opioid activity and its adverse effects, and hence, it might provide a good target to design new drugs that prevent or avoid these effects.
authors: Department of Biochemistry and Molecular Biology, Institute of Neuroscience of Castilla y León, University of Salamanca, Spain.
authors: F M
authors: FM
authors: Sanchez-Simon
authors: A S
authors: AS
authors: Ledo
authors: R
authors: R
authors: Arevalo
authors: R E
authors: RE
authors: Rodriguez
mesh_terms: D000367:Age Factors; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D004347:Drug Interactions; D004625:Embryo, Nonmammalian / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives / Q000494:pharmacology; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects*; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D017465:Receptors, Opioid, delta / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D051155:Wnt1 Protein / Q000235:genetics / Q000378:metabolism*; D015027:Zebrafish / Q000196:embryology
chemical_list: D000701:Analgesics, Opioid; D001549:Benzamides; C504157:Met-enkephalin-glycyl-tyrosine; D009292:Narcotic Antagonists; D010879:Piperazines; D017465:Receptors, Opioid, delta; D051155:Wnt1 Protein; C088464:4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide; D009270:Naloxone; D004744:Enkephalin, Methionine; D009020:Morphine